Skip to content

Safety and efficacy of ciprofol in day surgery

Safety and efficacy of ciprofol in day surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060937
Enrollment
Unknown
Registered
2022-06-14
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesiology

Interventions

ciprofol: ciprofol

Sponsors

The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1)Day surgery, intubation under general anesthesia 2)18 years old < age < 60 years old 3) ASA I-II level 4)18 kg/m2<BMI<28 kg/m2 5)Voluntarily participate in this study and sign informed consent

Exclusion criteria

Exclusion criteria: Change of surgical mode; Having a severe allergic reaction

Design outcomes

Primary

MeasureTime frame
Sedative effect (sedative induction time, operative time, sedative waking time, etc);

Secondary

MeasureTime frame
The incidence of adverse reactions such as injection pain,hypotension,respiratory depression and hypoxemia;Patient satisfaction and surgeon satisfaction;

Countries

China

Contacts

Public ContactJianhong-Xu
xujh1969@163.com18867961109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026